CYTEGRITY Trademark

Trademark Overview


On Friday, October 20, 2023, a trademark application was filed for CYTEGRITY with the United States Patent and Trademark Office. The USPTO has given the CYTEGRITY trademark a serial number of 98232757. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, January 14, 2025. This trademark is owned by CSL Behring Gene Therapy, Inc.. The CYTEGRITY trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Cell lines for medical purposes; Cells for medical or clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating cancer, tumors, genetic diseases, immunodeficiency conditions, stem cell transplantation, and transplant medicine; Biological preparations, namely, viral vectors and gene therapy vectors for therapeutic use and clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for treating a wide range of diseases, illnesses or conditions; Cell lines for medical purposes, namely, cell therapy; Cell lines for medical purposes, namely, immunotherapy; Cell lines for medical purposes, namely, for use as therapeutics to repair, replace or preserve cells and tissues; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating genetically engineered tissues and for treating transplant conditions; Biological preparations, namely, viral vectors a...

Cell lines, being cells, for scientific and research use; Cells for scientific, laboratory or medical research; Biological preparations, namely, viral vectors and gene vectors for scientific, laboratory or medical research; Cell lines for clinical laboratory use; cell lines for scientific research, namely, cell lines for gene expression and for the synthesis of biological compounds; cells for scientific, laboratory, or medical research, namely, cells for gene expression systems and for the synthesis of biological compounds; viral vectors for use in science and industry
cytegrity

General Information


Serial Number98232757
Word MarkCYTEGRITY
Filing DateFriday, October 20, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, January 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 14, 2025

Trademark Statements


Goods and ServicesCell lines for medical purposes; Cells for medical or clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating cancer, tumors, genetic diseases, immunodeficiency conditions, stem cell transplantation, and transplant medicine; Biological preparations, namely, viral vectors and gene therapy vectors for therapeutic use and clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for treating a wide range of diseases, illnesses or conditions; Cell lines for medical purposes, namely, cell therapy; Cell lines for medical purposes, namely, immunotherapy; Cell lines for medical purposes, namely, for use as therapeutics to repair, replace or preserve cells and tissues; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating genetically engineered tissues and for treating transplant conditions; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating viral and infectious diseases; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; viral vectors for medical use relating to gene therapy; gene therapy vectors for medical use
Goods and ServicesCell lines, being cells, for scientific and research use; Cells for scientific, laboratory or medical research; Biological preparations, namely, viral vectors and gene vectors for scientific, laboratory or medical research; Cell lines for clinical laboratory use; cell lines for scientific research, namely, cell lines for gene expression and for the synthesis of biological compounds; cells for scientific, laboratory, or medical research, namely, cells for gene expression systems and for the synthesis of biological compounds; viral vectors for use in science and industry

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, October 25, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 25, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCSL Behring Gene Therapy, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPasadena, CA 91101

Party NameCSL Behring Gene Therapy, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPasadena, CA 91101

Trademark Events


Event DateEvent Description
Tuesday, October 24, 2023NEW APPLICATION ENTERED
Wednesday, October 25, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 5, 2024ASSIGNED TO EXAMINER
Thursday, June 13, 2024NON-FINAL ACTION WRITTEN
Thursday, June 13, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 13, 2024NON-FINAL ACTION E-MAILED
Wednesday, September 11, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, September 11, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, December 11, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 11, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 11, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 17, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 8, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 14, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 14, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED